Trademark Attorney / Law Firm
Matthew J. Melancon – Trademark Portfolio
Matthew J. Melancon has 5 trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 3 trademarks are successfully registered — a 75% registration rate, with an additional 1 application currently pending. The strongest areas of practice include Class 9 (Computers & Electronics) and Class 43 (Hotels & Restaurants). Filing activity has been recorded from 2013 through 2024, spanning 2 years.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Matthew J. Melancon's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademark applications has Matthew J. Melancon filed?
Matthew J. Melancon has filed 5 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 3 registered, 1 pending, 1 abandoned.
What trademark classes does Matthew J. Melancon specialize in?
Matthew J. Melancon has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 9 (Computers & Electronics), Class 43 (Hotels & Restaurants), Class 5 (Pharmaceuticals). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
How long has Matthew J. Melancon been filing trademarks?
Matthew J. Melancon's trademark filing history with the USPTO spans from 2013 to 2024, covering 11 years of trademark practice. During this period, Matthew J. Melancon has handled 5 trademark applications.
What is Matthew J. Melancon's trademark registration success rate?
Matthew J. Melancon has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.